Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
主要な著者: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2006
|
類似資料
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
著者:: Mukhtyar, C, 等
出版事項: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
著者:: Mukhtyar, C, 等
出版事項: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
著者:: Saket Jha, 等
出版事項: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
著者:: Zhi-Ying Li, 等
出版事項: (2020-08-01) -
A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
著者:: Mahmoud M. Mohamed, 等
出版事項: (2023-07-01)